Source: Health Canada shortage reports · Updated Jul 29, 2026
Some Donepezil products are in shortage in Canada (14 of 39 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 23, 2026.
A medication used to treat symptoms of Alzheimer's disease.
Products affected
14 / 39
In shortage since
Nov 28, 2018
Est. full return
Oct 23, 2026
Reports on file
101
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP-DONEPEZIL TABLETS
5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02416948 · since Apr 21, 2026, est. end Aug 14, 2026 · Disruption of the manufacture of the drug.
Active shortage
ARICEPT
5MG · TABLET · PFIZER CANADA ULC
DIN 02232043 · since Apr 21, 2026, est. end Oct 23, 2026 · Requirements related to complying with good manufacturing practices.
Active shortage
ARICEPT
10MG · TABLET · PFIZER CANADA ULC
DIN 02232044 · since Apr 21, 2026, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
PMS-DONEPEZIL
5MG · TABLET · PHARMASCIENCE INC
DIN 02322331 · since Jun 26, 2026, est. end Aug 13, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-DONEPEZIL
5MG · TABLET · TEVA CANADA LIMITED
DIN 02340607 · since Jan 30, 2025, est. end Oct 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACH-DONEPEZIL
10MG · TABLET · ACCORD HEALTHCARE INC
DIN 02402653 · since Nov 5, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-DONEPEZIL
5MG · TABLET · APOTEX INC
DIN 02362260 · since Nov 18, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-DONEPEZIL
10MG · TABLET · APOTEX INC
DIN 02362279 · since Aug 6, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
NAT-DONEPEZIL
5MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02439557 · since Jun 13, 2024, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAT-DONEPEZIL
10MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02439565 · since Apr 21, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAT-DONEPEZIL
5MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02439557 · since Jun 13, 2024, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-DONEPEZIL
10MG · TABLET · TEVA CANADA LIMITED
DIN 02340615 · since Mar 5, 2025, no end estimate · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Donepezil is currently affected by 14 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, PFIZER CANADA ULC, PHARMASCIENCE INC, TEVA CANADA LIMITED and 5 others.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices; supply issues; supply issues; slow moving pack size so temporarily stopped procurement for this pack size of 30s. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Donepezil is classified under “ANTI-DEMENTIA DRUGS” (ATC N06DA).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Aug 7, 2026 → Aug 14, 2026
Jul 15, 2026
Estimated end date moved earlier : null → Oct 23, 2026
Jul 13, 2026
Estimated end date pushed back : Jul 28, 2026 → Aug 13, 2026
Common questions
What is Donepezil used for?
A medication used to treat symptoms of Alzheimer's disease.
When will Donepezil be back in stock in Canada?
The latest manufacturer estimate is Oct 23, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Donepezil in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.